Amiko Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.7M
Latest Deal Amount
  • Investors
  • 5

Amiko General Information

Description

Developer of a disease management platform designed to assist healthcare professionals and empower patients to achieve better outcomes. The company's platform includes medication sensors that collect unique inhalation data to permit monitoring compliance with lung function and disease progression, thereby enabling hospitals to access remote monitoring tools, AI-enabled therapy suggestions, and data analytics to make smarter decisions.

Contact Information

Website
www.amiko.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Studio 3.1, Bank Studios
  • Park Royal Road
  • London NW10 7LQ
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amiko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 18-Dec-2017 $1.7M 00.000 Completed Generating Revenue
5. Grant 08-Dec-2017 00.00 00000 Completed Generating Revenue
4. Seed Round 27-Jan-2016 00000 00000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
1. Product Crowdfunding 29-Jan-2014 Completed Startup
To view Amiko’s complete valuation and funding history, request access »

Amiko Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 000.00 000.00 00 000.00 00.00
To view Amiko’s complete cap table history, request access »

Amiko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a disease management platform designed to assist healthcare professionals and empower patients to achieve b
Therapeutic Devices
London, United Kingdom
19 As of 2021
00.000
000000000 00.000

00000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000000 0000000
Thornbury, Australia
00 As of 0000
000.00
000000&0

0000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
00000000000 0000000
Manchester, United Kingdom
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amiko Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adherium Formerly VC-backed Thornbury, Australia 00 000.00 000000&0
0000000 Accelerator/Incubator Backed Manchester, United Kingdom 00000 000000000000 00000
000000 000000 Formerly VC-backed New York, NY 0 000.00 000000&0 000.00
0000000 (000000000 Venture Capital-Backed Mountain View, CA 000 0000 000000000000 0000
00000 000000 Venture Capital-Backed Hoboken, NJ 00 000.00 000000000000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Amiko Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Amiko Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200171251-A1 Accessory for an inhaler, inhaler and method for detecting a drug administration process Pending 28-Jul-2017 00000000000
EP-3658210-A1 Accessory for an inhaler, inhaler and method for detecting a drug administration process Pending 28-Jul-2017 000000000
JP-2020528813-A Inhaler accessories, inhalers and methods for detecting drug administration processes Pending 28-Jul-2017 00000000000
US-10842434-B2 Device for controlling the intake of drugs, system for signaling and controlling the intake of drugs Active 16-May-2013 000000000 00
EP-2997510-A1 Device for controlling the intake of drugs, system for signaling and controlling the intake of drugs Granted 16-May-2013 G16H20/13
To view Amiko’s complete patent history, request access »

Amiko Executive Team (5)

Name Title Board Seat Contact Info
Duilio Macchi Co-Founder & Chief Executive Officer
Alexander Marinov Co-Founder & Chief Financial Officer
Alessandro Fato Co-Founder & Chief Technology Officer
Martijn Grinovero Co-Founder, Chief Marketing Officer & Chief Commercial Officer
Roberto Lucini Project Development Manager
To view Amiko’s complete executive team members history, request access »

Amiko Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amiko Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sanner Ventures Venture Capital Minority 000 0000 000000 0
IBM Watson AI XPRIZE Other 000 0000 000000 0
Breed Reply Corporate Venture Capital Minority 000 0000 000000 0
EIT Digital Accelerator/Incubator Minority 000 0000 000000 0
I3P Accelerator/Incubator 000 0000 000000 0
To view Amiko’s complete investors history, request access »

Ready to get started?

Request a free trial